Emergent BioSolutions Inc. — Director's Dealing 2015

Aug 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-08-13

Reporting Person: JOULWAN GEORGE A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock	M	7200	$17.51	Acquired	26700	Direct
2015-08-13	Common Stock	S	7200	$34.72	Disposed	19500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-13	Common Stock	$17.51	M	7200	Disposed	2020-07-16	Common Stock (7200)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on July 17, 2013.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.71 to $34.81, inclusive.

F3: The option vests in three equal installments in July 2014, 2015 and 2016.